NYSE:BMY

Bristol-myers Squibb Stock Insider Trading

Healthcare > Drug Manufacturers - General

Buy BMY

*Your capital is at risk

$64.84

+0.120 (+0.185%)

At Close: Aug 10, 2026

Bristol-Myers Squibb Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 27.79. In total, the insiders bought 715.68M and sold 128.8K BMY shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	27.79
● Buy	715.68M shares
● Sell	128.8K shares
64% Buy Activity Negligible or No Correlation
Sell Signal Low Confidence Apr 01, 2026 Analysis Breakdown: Signal is highly questionable due to a strongly contradictory positive Insider Power Score of 27.79. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Mar 10, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	2 448 Value: $147.2K
Mar 10, 2026 Buy	Performance Shares A-Award	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	31 837 Value: $1.91M
Mar 10, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Shanahan Karin EVP, Chief Supply Chain & Ops	Officer	19 760 Value: $1.19M
Mar 10, 2026 Buy	Market Share Units M-Exempt	Short Bartie Wendy EVP, Corporate Affairs	Officer	639 Value: $38.4K
Mar 10, 2026 Buy	Performance Shares M-Exempt	Short Bartie Wendy EVP, Corporate Affairs	Officer	4 495 Value: $270.3K
Mar 10, 2026 Buy	Market Share Units M-Exempt	Short Bartie Wendy EVP, Corporate Affairs	Officer	749 Value: $45.0K
Mar 10, 2026 Sell	Common Stock, $0.10 par value F-InKind	Short Bartie Wendy EVP, Corporate Affairs	Officer	242 Value: $14.6K
Mar 10, 2026 Buy	Market Share Units A-Award	Short Bartie Wendy EVP, Corporate Affairs	Officer	6 531 Value: $392.7K
Mar 10, 2026 Sell	Common Stock, $0.10 par value J-Other	Short Bartie Wendy EVP, Corporate Affairs	Officer	81 Value: $0
Mar 10, 2026 Buy	Performance Shares A-Award	Shibutani Hiroshi Chris EVP, Chief Strategy Officer	Officer	11 755 Value: $706.8K
Mar 10, 2026 Buy	Market Share Units A-Award	Hickey Benjamin President, Rayzebio Org.	CEO / President	11 429 Value: $687.2K
Mar 10, 2026 Buy	Performance Shares A-Award	Hickey Benjamin President, Rayzebio Org.	CEO / President	17 143 Value: $1.03M
Mar 10, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Lenkowsky Adam EVP, Chief Commercial Officer	Officer	2 000 Value: $120.3K
Mar 10, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Meyers Gregory Scott EVP, Chief Digital & Tech Off.	Officer	19 760 Value: $1.19M
Mar 10, 2026 Buy	Market Share Units A-Award	Meyers Gregory Scott EVP, Chief Digital & Tech Off.	Officer	26 122 Value: $1.57M
Mar 10, 2026 Sell	Common Stock, $0.10 par value J-Other	Meyers Gregory Scott EVP, Chief Digital & Tech Off.	Officer	356 Value: $0
Mar 10, 2026 Sell	Common Stock, $0.10 par value F-InKind	Meyers Gregory Scott EVP, Chief Digital & Tech Off.	Officer	1 246 Value: $74.9K
Mar 10, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Meyers Gregory Scott EVP, Chief Digital & Tech Off.	Officer	2 839 Value: $170.7K
Mar 10, 2026 Sell	Common Stock, $0.10 par value J-Other	Meyers Gregory Scott EVP, Chief Digital & Tech Off.	Officer	319 Value: $0
Mar 10, 2026 Buy	Market Share Units A-Award	Lenkowsky Adam EVP, Chief Commercial Officer	Officer	32 653 Value: $1.96M
Mar 10, 2026 Buy	Common Stock, $0.10 par value M-Exempt	Lenkowsky Adam EVP, Chief Commercial Officer	Officer	12 002 Value: $721.7K
Mar 10, 2026 Sell	Common Stock, $0.10 par value F-InKind	Lenkowsky Adam EVP, Chief Commercial Officer	Officer	3 125 Value: $187.9K
Mar 10, 2026 Buy	Market Share Units A-Award	Shibutani Hiroshi Chris EVP, Chief Strategy Officer	Officer	7 837 Value: $471.2K
Mar 10, 2026 Buy	Performance Shares A-Award	Massacesi Cristian EVP,chief Med Offr,head Of Dev	Officer	39 184 Value: $2.36M
Mar 10, 2026 Buy	Market Share Units A-Award	Massacesi Cristian EVP,chief Med Offr,head Of Dev	Officer	26 122 Value: $1.57M

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT BRISTOL-MYERS SQUIBB COMPANY

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple myeloma; Eliquis, an oral inhibitor for reduction in risk of stroke/systemic embolism in NVAF, and for th...

Read Full Profile Here